The weight loss achieved with Foundayo has been evaluated in two Phase 3 clinical trials: In the ATTAIN-1 trial (adults with obesity or overweight without type 2 diabetes), participants taking the highest dose lost an average of approximately 11% of their body weight (around 25 pounds or 11 kg) over 72 weeks, compared to approximately 2% in the placebo group
Arch Pediatr 2:545547 Lacy SR, Kuhar M (2010) Melanotic neuroectodermal tumor of infancy presenting in the subcutaneous soft tissue of the thigh
When a healthy person eats food, their digestive system breaks down carbohydrates into glucose, which enters their bloodstreamThis rise in blood sugar triggers the pancreas, an organ near your stomach, to release insulin into the bloodstream
The FDA-approved use of this medication varies according to the brand names
The vials were emptied and ~ 5 mL dH2O was added to each vial
The temporal pattern may differ as well, with systemic effects potentially developing more gradually or persisting beyond the immediate post-injection period